Effects of insulin and analogues on carcinogen-induced mammary tumours in high fat-fed rats. Lillehammer (1994) 75 92. Analytica pro, Nachrichten aus der Chemie, (2008) 22 23 Flenker U, Lüdke S, Güntner U, Schänzer W: Which factors control 13C/12C-ratios of urinary steroids? 2011, 41, 81-90. Nolteernsting, E., Geyer, H., Mareck-Engelke, U., Schänzer, W., Donike, M.: Standardisation of the T/E-determination by deuterated internal standards. GIT Labor-Fachzeitschrift 10 (2001) 1096-1098 Sigmund, G., Opfermann, G., Seinsch, I., Schänzer, W.: Detection of bupropion and metabolites. Breidbach, A., Platen, P., Schänzer, W.: Erythropoietine-Influence of physical strain and application on blood and urine. 2017; Apr 7. doi: 10.1111/jvp.12408. Deutsche Pharmazeutische Gesellschaft, Frankfurt, 2009, 235 Parr MK, Geyer H, Gütschow M, Schänzer W: Recent steroid findings in “designer supplements”. ), Ars Medici, Phytotherapie 1 (2010), 38 – 40. Recent advances in doping analysis (10). Landschaftsverband Westfalen-Lippe, Münster (2004). Sportmedizin in Nordrhein, Mitgliederjournal, 2013 Ausgabe 2, 12-17. Forensic Toxicol. 2020; 71: 216-224. doi:10.5960/dzsm.2020.455, Ziegenhagen R, Braun H, Carlsohn A, Großhauser M, Heseker H, König D, Mosler S, Nieß A, Oberritter H, Schäbethal K, Schek A, Stehle P, Virmani K, Lampen A: Safety aspects of dietary supplements in sports. J.Chromatogr.Sci. Drug Test Anal. Proceedings of the 2nd annual USADA Symposium on anti-doping-science, Los Angeles, USA August 21-24, 2003. Soc. Chromatogr. Accred Qual Assur DOI 10.1007/s00769-009-0585-9 Flenker U, Linster B, Gougoulidis V, Hülsemann F, Schänzer W: Possible absence of lipid 13C depletion in sterols and steroids from eukaryotes. Recent advances in doping analysis (9). CD Rom.Wiley-VCH Verlag GmbH & Co. KGaA. Eur J Appl Physiol. Sport und Buch Strauß, Köln (2002) 211 216 PDF-file Mareck-Engelke, U., Sigmund, G., Opfermann, G., Geyer, H., Schänzer, W.: Identification of the aromatase inhibitor aminogluthedimide in urine by gas-chromatography/mass spectrometry. Unusual Mass Spectrometric Dissociation Pathway of Protonated Isoquinoline-3-Carboxamides Due to Multiple Reversible Water Adduct Formation in the Gas Phase. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) R & W Publications Ltd., Newmarket (ISBN 978 0 473 22084 6), 50 - 57 Mareck U, Fußhöller G, Geyer H, Opfermann G, Thevis M, Schänzer W: GC -single and -triple quadrupole mass spectrometry in steroid profiling. Gütegemeinschaft Gesundheitssportzentrum. Drug Test Anal. Dtsch. 2010; 24: 2245 2254 Mario Thevis, Andreas Thomas, Maxie Kohler, Simon Beuck, Ines Möller, Mathias Schäfer, Grigory Rodchenkov, Sheng Yin, Joseph A. Loo, Hans Geyer, and Wilhelm Schänzer: Mass spectrometry-based characterization of new drugs and methods of performance manipulation in doping control analysis. Mass Spectrom. Eur. and Vets. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Sport und Buch Strauß, Köln (2006) 87 89 Thomas A, Thevis M, Delahaut P, Bosseloir A, Schänzer W: Qualitative determination of rapid acting synthetic insulin analogues in urine by means ofLC-MS/MS. Sport und Buch Strauß, Köln (2003) 365 372 Flenker, U., Schänzer, W: Expression of differences in isotopic composition. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) CRC Press, Boston - London - New York, 1998, 671-689. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Sport und Buch Strauß, Köln (2006) 343 344 2005 Buisson, C., Hebestreit, M., Press Weigert, A., Heinrich, K., Fry, H., Flenker, U., Banneke, S., Prevost, S., Andre, F., Schaenzer, W., Houghton, E., Le Bizec, B.: Application of stable isotope analysis to the detection of 17ß-estradiol administration to cattle. 2018 Mar 15;464:34-45. doi: 10.1016/j.mce.2017.01.040. Recent advances in doping analysis (18). Low energy availability in exercising men is associated with reduced leptin and insulin but not with changes in other metabolic hormones. Sport und Buch Strauß, Köln (2004) 251 259 Gougoulidis, V., Flenker, U., Platen, P., Schänzer, W.: Changes of 13C/12C in free fatty acids during a four month-long health orientated fitness training with an obese patient - a case study -. Drug Test Anal. PHARMAKON. Geyer, H., Berschick, P., Mareck-Engelke, U., Schänzer, W.: DNA Typing for the confirmation of manipulation in dope control. The intravenous pharmacokinetics of butorphanol and detomidine dosed in combination compared with individual dose administrations to exercised horses. 2018 Nov;10(11-12):1755-1760. doi: 10.1002/dta.2503. In: Loland S, Bø K, Fasting K, Hallén J, Ommundsen Y, Roberts G, Tsolakidis E (eds.). Sport und Buch Strauß, Köln , (1997) 261-270. Recent advances in doping analysis (9). In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) 2020;12(7):994-997. Sportverlag Strauß, Köln (2008) 285 288 Geyer H, Parr MK, Koehler K, Mareck U, Schänzer W, Thevis M: Nutritional supplements cross-contaminated and faked with doping substances. Bruges, Belgium (2012), 237 Bredehöft M, Baginski R, Parr MK, Thevis M, and Schänzer,W: Investigations of the microbial transformation of cortisol to prednisolone in urine samples. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Methods in Enzymology. Vienna, August 30-September 3, 2004. Handbook of Experimental Pharmacology 195, Springer, Heidelberg, Dordrecht, London, New York, 2010, 209-226 Thevis M, Bredhöft M, Kohler M, Schänzer W: Mass spectrometry-based analysis of IGF-1 and hGH. Deutscher Sportärztekongress. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (2). In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Sport und Buch Strauß, Köln (2005) 245 254 Thevis, M., Ogorzalek-Loo, R.R., Loo, J.A., Bredehöft, M., Schänzer, W. Probing for Characteristics of Growth Hormone by LC-ESI-MS/MS. ... an der Deutschen Sporthochschule Köln den 2- bzw. 2011 Apr 1. Sport und Buch Strauß, Köln (2003) 85 90 Mareck, U., Sigmund, G., Opfermann, G., Geyer, H., Schänzer, W.: Identification of Non-steroidal Aromatase Inhibitors in Doping Analysis. Recent advances in doping analysis (16). Hast du teilgenommen und den Test erfolgreich gemeistert, ist dein Ergebnis für drei Jahre gültig. FIMS 7th European Sports Medicine Congress, Nicosia, Cyprus 1993, 35 Strüder, H.K., W. Hollmann, P. Platen, M. Donike, A. Gotzmann: Prolactin response to endurance exercise in relation to altered levels of plasma neutral amino acids and plasma free tryptophan. Nutrients. Testosterone – Action,Deficiency,Substitution. In: M. Donike, H.Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) 2013 Jul;48(7):830-43. doi: 10.1002/jms.3227. Dib, J. Tretzel, L. Piper, T. Lagojda, A. Kuehne, D. Schänzer, W. Thevis, M. Screening for adiponectin receptor agonists and their metabolites in urine and dried blood spots. 74, (1996) 443 449 Breidbach, A., Sigmund, G.: Combination of screening procedures-Mesocarb Detection as an example. Recent advances in doping analysis (27). (eds.) 2017 Jul 30;31(14):1175-1183. Sport und Buch Strauß, Köln , (1997) 107-126. Thevis, M., Opfermann, G., Schänzer, W.: Nachweis des Plasmavolumenexpanders Hydroxyethlstärke in Humanurin. Epub 2019 Aug 8. Seniorenfahrt: Fitness-Test in der Kölner Sporthochschule und im RheinEnergieStadion (11. ; Fernandez-Elias, V.E. Drug Test Anal. Recent advances in doping analysis (17). Routledge, London, New York, 2015, 15-19 Görgens C, Guddat S, Orlovius AK, Sigmund G, Thomas A, Thevis M, Schänzer W: "Dilute-and-inject" multi-target screening assay for highly polar doping agents using hydrophilic interaction liquid chromatography high resolution/high accuracy mass spectrometry for sports drug testing. 20 (2014) 73–83 Thevis M, Sigmund G, Thomas A, Vogel M, Walpurgis K, Kwiatkowska D, Geyer H, Schänzer W. Isotope-dilution mass spectrometric quantification of the prodrug lisdexamfetamine in human urine in doping control analysis. Schriftenreihe des Bundesinstituts für Sportwissenschaft Band 86, Verlag Karl Hofmann, Schorndorf (1996) 127 151 Geyer, H., Schänzer, W., Mareck-Engelke, U., Donike, M.: Factors influencing the steroid profile. Chromatographia 62 (2005) 435 439 Thevis, M., Schänzer, W.: Mass spectrometric analysis of androstan-17ß-ol-3-one and androstadiene-17ß-ol-3-one isomers. 2012 Dec 15;26(23):2714-24. doi: 10.1002/rcm.6398. Aktuel. Vienna, August 30-September 3, 2004. [Epub ahead of print] Mario Thevis, Andreas Thomas, Simon Beuck, Anthony Butch, Jiri Dvorak and Wilhelm Schänzer: Does the analysis of the enantiomeric composition of clenbuterol in human urine enable the differentiation of illicit clenbuterol administration from food contamination in sports drug testing? Recent advances in doping analysis (5). Sportverlag Strauß, Köln (2008) 211 212 Van Renterghem P, Van Eenoo P,Van Thuyne W, Geyer H, Schänzer W, Delbeke FT: Validation of an extended method for the detection of the misuse of endogenous steroids in sports, including new hydroxylated metabolites. Kambouris, M., Platen, P., Donike, M.: Detection of human growth hormone in urine of athletes. J Pharm Biomed Anal. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Lebensmittelchemie, 62 (2008) 76 Parr MK, Koehler K, Geyer H, Guddat S, Schänzer W. Clenbuterol marketed as dietary supplement. [Epub ahead of print] Machnik M, Schenk I, Düe M. Schänzer W. Medikamentenkontrolle im Pferdesport unter Berücksichtigung von pharmakologisch wirksamen Konzentrationen. Romberg S , Sauer M , Klose C , Schänzer W , Thevis M: Paperless Communication of Sample Collection Documentation. J Pharm Biomed Anal. doi:10.1371/journal.pone.0056759 Guddat S, Fußhöller G, Beuck S, Thomas A, Geyer H, Rydevik A, Bondesson U, Hedeland M, Lagojda A, Schänzer W, Thevis M: Synthesis, characterization, and detection of new oxandrolone metabolites as long-term markers in sports drug testing. J Strength Cond Res 25(5): 1271 1278, 2011 Mario Thevis, Gregor Fußhöller, Wilhelm Schänzer: Zeranol: doping offence or mycotoxin? CLB Chemie in Labor und Biotechnik, 54.Jahrgang, Heft 05/2003. Fußhöller G, Guddat S, Schänzer W, Geyer H, Thevis M: Testolactone – Derivatisation Artifact due to the Incorporation of an Ethylmercapto Group. Lehmann S, Thomas A, Schiwy-Bochat KH, Geyer H, Thevis M, Glenewinkel F, Rothschild MA, Andresen-Streichert H, Juebner M. Death after misuse of anabolic substances (clenbuterol, stanozolol and metandienone). In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (20). In: Schänzer W, Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (8). [Epub ahead of print] Reichel C, Benetka W, Lorenc B, Thevis M. Evaluation of AMGEN clone 9G8A anti-Epo antibody for application in doping control. Thevis M, Thomas A, Schänzer W. Current role of LC-MS(/MS) in doping control. Das Wissenschaftsmagazin, 1 ( 2009) 14-17 Thevis M, Sigmund G, Thomas A, Gougoulidis V, Rodchenkov G, Schänzer W: Doping control analysis of metamfepramone and two major metabolites using liquid chromatography-tandem mass spectrometry. Flenker, U., Güntner, U. Schänzer, W.:13C/12C-Measurment of 17-Ketosteroids to detect abuse of androgenic steroids in sport. Dopingkontrollaktivitäten bei den Paralympischen Spielen 1984 2008 und in Deutschland 1992 2008. Über die Effizienz von Dopingkontrollen und Nebenwirkungen verbotener Substanzen. in: M.Donike, H.Geyer, A.Gotzmann, U.Mareck-Engelke (Eds.) In C.R.Short (Ed), Procceedings of the 9th International Conference of Racing Analysts and Veteriarians, New Orleans, 1992, 17-35. W.: Electrospray ionization mass spectrometric characterization and quantitation of xanthine derivatives using isotopically labelled analogues: an application for equine doping control analysis. 2013, 27, 507–512 Mario Thevis, Thomas Piper, Simon Beuck, Hans Geyer and Wilhelm Schänzer: Expanding sports drug testing assays: Mass spectrometric characterization of the selective androgen receptor modulator drug candidates RAD140 and ACP-105. Loo, R.R., Loo, J. Anal Methods. Flenker, U., Schänzer, W.: Kinetic isotope effects during metabolism of D4-steroids. Sport und Buch Strauß, Köln (2006) 101 110 Mareck, U., Geyer, H., Guddat, S., Haenelt, N., Koch, A., Kohler, M., Opfermann, G., Thevis, M., Schänzer, W.: Identification of the aromatase inhibitors anastrozole and exemestane in human urine using liquid chromatography/tandem mass spectrometry. Abstract 2002 Geyer, H., Bredehöft, M., Mareck, U., Parr, M., Schänzer, W.: Hohe Dosen des Anabolikums Metandienon in Nahrungsergänzungsmitteln gefunden. Sport und Buch Strauß, Köln (2002). In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) doi: 10.1371/journal.pone.0150453. In: Kraemer, W.J., Rogol, A.D. Sportverlag Strauß, Köln (2011) 309 312 Guddat S, Solymos E, Orlovius A, Thomas A, Sigmund G, Geyer H, Thevis M, Schänzer W. High-throughput screening for various classes of doping agents using a new 'dilute-and-shoot' liquid chromatography-tandem mass spectrometry multi-target approach. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Schänzer W., Gotzmann A., Horning S. and Donike M.: Trimethylsilyl derivatisation of endogenous and synthetic corticosteroids for GC/MS Identification. (ed.) Es warten insgesamt 5 Aufgaben auf Sie, die etwa 10 Minuten in Anspruch nehmen. Sport und Buch Strauß, Köln (1995) 269-274. Deutsche Zeitschrift für Sportmedizin (Sonderdruck), 44 (1993) 329 -341. J Sports Sci. Physical, Nutritional and Psychological care of the Athlete in the 21st century. Epub ahead of print. J Clin Endocrin Metab, 92 (207) 2893-2901 Piper T, Hebestreit M, Flenker U, Geyer H, Schänzer W: A new method to determine d13CVPDB-values of trace amounts of Boldenone and its main metabolite. Braun, H., Koehler, K., Geyer, H., Mester, J., Thevis, M., Schaenzer, W. Dietary supplement use, impact on micronutrient intake of young German athletes. Epub 2016 Mar 28. Dstch. Sportverlag Strauß, Köln, 2017, 60-62. KleineS Handbuch der Lehre an der DSHS Köln. Sport und Buch Strauß, Köln (2000) 155-174. Recent advances in doping analysis (20). Council of Europe, Committee for the development of sports. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) 2011, DOI: 10.1016/j.aca.2011.09.027 Thomas A, Kohler M, Schänzer W, Delahaut P, Thevis M. Determination of IGF-1 and IGF-2, their degradation products and synthetic analogues in urine by LC-MS/MS. Recent advances in doping analysis (14). 2011, 15, 2187-95 Thevis M, Geyer H, Thomas A, Schänzer W. Trafficking of drug candidates relevant for sports drug testing: Detection of non-approved therapeutics categorized as anabolic and gene doping agents in products distributed via the Internet. Eur. Sportverlag Strauß, Köln (2011) 112 Piper T, Fußhöller G, Emery C, Schänzer W, Saugy M: Investigations on carbon isotope ratios and concentrations of urinary formestane. Mohr Siebeck, Tübingen, 2010, 13-21 Thevis M, Möller I, Thomas A, Beuck S, Rodchenkov G, Bornatsch W, Geyer H, Schänzer W: Characterization of two major urinary metabolites of the PPARdelta-agonist GW1516 and implementation of the drug in routine doping controls. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Walpurgis K, Thomas A, Dellanna F, Schänzer W, Thevis M. Detection of the Human Anti-ActRII Antibody Bimagrumab in Serum by Means of Affinity Purification, Tryptic Digestion, and LC-HRMS. 32 (2008) 232 240 Thevis M, Kohler M, Schlörer N, Schänzer W: Gas phase reaction of substituted isoquinolines to carboxylic acids in ion trap and triple quadrupole mass spectrometers after electrospray ionization and collision-induced dissociation. Rapid Commun. GIT Labor-Fachzeitschrift. Drug Test Anal. Analysis 2009, 1, 587-595 Flenker U: Recent developments in stable isotope research: Joint European Stable Isotope User Meeting 2008. 2013, 5, 810-818 Thevis M, Thomas A, Schänzer W: Targeting prohibited substances in doping control blood samples by means of chromatographic-mass spectrometric methods. Sportverlag Strauß, Köln (2010) 152 155 Palm FM, Schenk I, Neuhauser S, Schubert D, Machnik M, Schänzer W, Aurich C:Concentrations of altrenogest in plasma of mares and foals and in allantoic and amniotic fluid at parturition. Recent advances in doping analysis (22). Möller I, Thomas A, Delahaut P, Geyer H, Schänzer W, Thevis M: Mass spectrometric detection of peginesatide in human urine in doping control analysis. J Mass Spectrom. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Anal. Proceedings of the Tenth International Conference of Racing Analysts and Veterinarians, Stockholm (1994) 307 309 Horning S., Schänzer W., Sigmund G. Donike M.: High resolution GC/MS: Determing steroid concentrations in equine and human plasma. Sport und Buch Strauß, Köln (2001) 107 114 Thevis, M., Opfermann, G., Schänzer, W.: Screening and confirmation methods for the detection of plasma volume expanders in human urine. 2017 Aug 4:1-9. doi: 10.1080/14789450.2017.1362338, Thomas A, Walpurgis K, Delahaut P, Fichant E, Schänzer W, Thevis M. Determination of LongR3-IGF-I, R3-IGF-I, Des1-3 IGF-I and their metabolites in human plasma samples by means of LC-MS. Growth Horm IGF Res. Recent advances in doping analysis (14). Sport und Buch Strauß (1997) 7-26 Schänzer, W.: Doping und Dopinganalytik. Drug Testing and Analysis 2011, 3, 11-12: 877-882. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Sport und Buch Strauß, Köln (2004) 109 119 Strompen, O., Opfermann, G., Enbergs, H., Schänzer, W.: Determination of endogenous steroid profiles in equine urine by gas chromatography/mass spectrometry. Recent advances in doping analysis (22). Recent advances in doping analysis (15). Recent advances in doping analysis (3). Recent advances in doping analysis (17). Poceedings of the 46th ASMS Conference on Mass Spectomtry and allied topics, 31.5-4.6.98. Geyer, H.: Screening for synthetic anabolic steroids and interpretation of steroidprofiles. Jahrestagung der Arbeitsgemeinschaft Stabile Isotope 08.-10.10.2007 Universität Bayreuth. Mario Thevis, Katja Walpurgis, Andreas Thomas and Hans Geyer. Abstractband. Horning, S., Schänzer, W., Donike, M.: Steroid Profiling in Human and Horse Blood: Some Results. 2016 Nov 27;134:228-236. doi: 10.1016/j.jpba.2016.11.041. BMC Vet Res. Chem., 74 (2002) 3802 8 download als PDF-file Thevis, M., Opfermann, G., Schänzer, W.: Mass spectrometric characterization of glucuronic acid conjugates of anabolic androgenic steroids and their metabolites. [Epub ahead of print] Thevis M, Thomas A, Schänzer W. Doping control analysis of selected peptide hormones using LC-MS(/MS). The 37th Manfred Donike workshop on doping analysis - Editorial. In: M. Gamper, J. Mühlethaler, F. Reidhaar (eds. Recent advances in doping analysis (14). PLoS One. Schänzer, W., Donike, M.: Metabolism of anabolic steroids in man: synthesis and use of reference substances for identification of anabolic steroid metabolites. Sport und Buch Strauß, Köln (2002) 235 240 2001 Bialas, , B., Schwenke, D., Schänzer, W., Müller, K.: Diurnal variation of indirect parameters for the detection of recombinant human erythropoietin abuse in athletes. Pearce, C. Hannan, M. Machnik, and L. Hillyer (2016). Anal Chem. Sportverlag Strauß, Köln (2015) 201 205 Piper T, Schänzer W, Thevis M. Revisiting the metabolism of 19-nortestosterone using isotope ratio and high resolution/high accuracy mass spectrometry. 15 (2001) 393 402 Thevis, M., Opfermann, G., Schmickler, H., Schänzer, W..: Mass spectrometry of steroid glucuronide conjugates. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Sportverlag Strauß, Köln (2010) 64 73 Parr MK, Westphal F, Sönnichsen FD, Geyer H, Schänzer W: 1-DHEA identification in seized dietary supplement. Conf. 2016 Oct;34(20):1921-9. doi: 10.1080/02640414.2016.1142109. Von diesen Cookies werden die als notwendig kategorisierten Cookies auf Ihrem Browser gespeichert, da sie für das Funktionieren der Grundfunktionen der Website unerlässlich sind. Sport und Buch Strauß, Köln (1998) 329 337 Machnik, M., Delahaut, P., Horning, S., Schänzer, W.: Preparation of Immuno Affinity columns. Geyer, H., Schänzer, W., Mareck-Engelke, U., Nolteernsting, E., Opfermann, G.: Screening procedure for anabolic steroids-The control of the hydrolysis with deuterated androsterone glucuronide and studies with direct hydrolysis. Recent advances in doping analysis (7). Chem. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Rapid Commun Mass Spectrom. Verbotene Substanzen als Verunreinigungen oder illegale Beimengung von Nahrungsergänzungsmitteln und damit verbundene gesundheitliche Risiken. Ihre Fitness-Vorteile. Sport und Buch Strauß, Köln (2006) 367 376 Thomas, A., Geyer, H., Mester, H.J., Schänzer, W., Zimmermann, E., Thevis, M.: Quantitative determination of adrenaline and nordadrenaline in urine using liquid chromatography-tandem mass spectrometry. 2018 Jan;10 (1): 9-27. : Posttranslational Hydroxylation of Human Phenylalanine Hydroxylase Is a Novel Example of Enzyme Self-Repair within the Second Coordination Sphere of Catalytic Iron. Sport und Buch Strauß, Köln (2004) 55 63 Gotzmann, A., Bredehöft, M., Thevis, M., Schänzer, W.: Detection of prednisolone, prednisone and 20ß-dihydroprednisolone in equine urine by means of LC/MS/MS. Dias KA, Lawley JS, Gatterer H, Howden EJ, Sarma S, Cornwell WK 3rd, Hearon CM Jr, Samels M, Everding B, Shuo-Wen Liang A, Hendrix M,Piper T, Thevis M, Bruick RK, Levine BD. J. Mareck-Engelke U., Geyer H. and Donike M.: Stability of steroid profiles (2): Excretion rates from morning urines. Wissenschaftsmagazin, 1 (2008) 14 17 Mario Thevis, Maxie Kohler, Andreas Thomas, Nils Schlörer and Wilhelm Schänzer: Doping control analysis of tricyclic tetrahydroquinoline derived selective androgen receptor modulators using liquid chromatography/electrospray ionization tandem mass spectrometry. 2013, 5, 853-860 Thomas A, Vogel M, Piper T, Krug O, Beuck S, Schänzer W, Thevis M: Quantification of AICAR-ribotide concentrations in red blood cells by means of LC-MS/MS. 2020 Jan 7;92(1):506-523. doi: 10.1021/acs.analchem.9b04639. Sportverlag Strauß, Köln (2007) 97 102. Application of gas chromatography-combustion-isotope ratio mass spectrometry to doping control. 2011 Feb;46(2):112-30 Beuck S, Möller I, Thomas A, Klose A, Schlörer N, Schänzer W, Thevis M. Structure characterisation of urinary metabolites of the cannabimimetic JWH-018 using chemically synthesised reference material for the support of LC-MS/MS-based drug testing. Thomas A, Thevis M. Analysis of insulin and insulin analogs from dried blood spots by means of liquid chromatography-high resolution mass spectrometry. Sportverlag Strauß, Köln (2007) 169 178 Piper T, Flenker U, Schänzer W: Untersuchungen zum D/H-Verhältnis endogener urinärer Steroide. Conf. 5 (2004) 440 443 Schrader, Y., Schänzer, W.: Plasma levels of 19-norsteroids after administration of oral and sublingual norandrostendione. Oslo, Norway (2009) 259 Koehler K, Huelsemann F, deMarees M, Braun H, Mester J, Schaenzer W. Nutrition strategies for a 3-week solo dessert crossing: a case study. Eur. 91 (2002) 357 362 download als PDF-file Wingender, A., Sigmund, G., Schänzer, W.: Local Anaesthetics in Sport. 20 (2006) 3393-3402 Thevis, M., Sigmund, G., Schiffer, A.K., Schänzer, W.: Determination of N-desmethyl- and N-bisdesmethyl metabolites of Sibutramine in doping control analysis using liquid chromatography-tandem mass spectrometry. Recent advances in doping analysis (5). Drug Test. 2011, 33, 471. J Sep Sci. (Red. Sport und Buch Strauß, Köln (2003) 227 237 Thevis, M., Sigmund, G., Schänzer, W.: Confirmation of Ephedrines - Comparison between GC-MS and LC-MS/MS. J Mass Spectrom, 41 (2006) 332 8 Thevis M, Horning S, Makarov A, Schänzer W: Mass spectrometric characterization of efaproxiral (RSR13) and stanozolol using electrospray ionization with high resolution/high accuracy mass spectrometry. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Das Wissenschaftsmagazin, 1 (2009) 4-11 Hülsemann F, Flenker U, Koehler K, Schaenzer W. Effect of a controlled dietary change on carbon and nitrogen stable isotope ratios of human hair. Recent advances in doping analysis (6). Sport und Buch Strauß, Köln (2003) 67 75 Parr, M.K., Geyer, H., Rommelfanger, J., Schänzer, W.: Anabole Steroide in Nahrungsergänzungsmitteln in Deutschland. Med. Handbook of Experimental Pharmacology 195, Springer, Heidelberg, Dordrecht, London, New York, 2010, 201-207 Thevis M, Schänzer W: Synthetic anabolic agents: Steroids and nonsteroidal selective androgen receptor modulators. Recent advances in doping analysis (22). 2015 Jan 15;29(1):61-6 Thevis M, Thomas A, Schänzer W: Detecting peptidic drugs, drug candidates and analogs in sports doping: current status and future directions. 2010 Nov;2(11-12):589-98 Thevis M, Schänzer W; Targeting new performance enhancing drugs in doping controls: Selective androgen receptor modulators (SARMs).
Hähnchen Pasta Auflauf,
Kaisergarten Oberhausen Plan,
Frauenanteil Medizinstudium 2018,
Prahlerei Kreuzworträtsel 11 Buchstaben,
Adipositas Reha Abgelehnt,
Uni Hamburg Master Psychologie,
Shroud Pubg Settings 2020,
Ausbildung Zur Sozialbetreuerin,
Takko Kleider Herren,
Speiseplan Mensa Leipzig,